SCHEMBL25833424

SCHEMBL25833424

N#Cc1cnc(-c2ccc(F)cc2)cc1-c1ccn(C2CC2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 4/20 0.38
TGFBR2 P37173 1/20 0.38
CSNK2A1 P68400 1/20 0.37
AR P10275 1/20 0.37
GABRA1 P14867 4/20 0.36
GABRG2 P18507 4/20 0.36
GABRB3 P28472 4/20 0.36
GABRA5 P31644 4/20 0.36
GABRA3 P34903 4/20 0.36
TRPA1 O75762 2/20 0.36
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
ABL1 P00519 2/20 0.35
NR3C1 P04150 1/20 0.35
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
NSD2 O96028 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30510017 0.86 CYP11B1 (0.41) TGFBR1TGFBR2CSNK2A1ARGABRA1
SCHEMBL25380379 0.86 CYP11B1 (0.41) TGFBR1TGFBR2CSNK2A1ARGABRA1
SCHEMBL25833132 0.84 TGFBR1 (0.38) TGFBR1TGFBR2ARGABRA1GABRG2
SCHEMBL25378298 0.82 SCN4A (0.49) CSNK2A1ARGABRA1GABRG2GABRB3
SCHEMBL26193080 0.79 CSNK2A1 (0.39) TGFBR1CSNK2A1ARGABRA1GABRG2
SCHEMBL1553745 0.78 SCN4A (0.46) TGFBR1ARCYP11B1CYP11B2ALDH1A1
SCHEMBL30509992 0.78 MEN1 (0.44) TGFBR1TGFBR2CSNK2A1ARALDH1A1
SCHEMBL25302131 0.78 MEN1 (0.44) TGFBR1TGFBR2CSNK2A1ARALDH1A1
SCHEMBL25299135 0.73 SCN9A (0.46) ARABL1
SCHEMBL30509972 0.71 CSNK2A1 (0.41) TGFBR1TGFBR2CSNK2A1GABRA1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 US disclosed
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 US disclosed
WO-2023122780-A9 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-11-30 WO disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 US disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 US disclosed
WO-2023122780-A2 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-06-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 TGFBR1 2525/4885TGFBR2 1779/4885CSNK2A1 1568/4885
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 TGFBR1 2525/4885TGFBR2 1779/4885CSNK2A1 1568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.